Indications and uses
temporarily relieves minor aches and pains due to: headache, the common cold, backache, minor pain of arthritis, toothache, muscular aches, premenstrual and menstrual cramps temporarily reduces fever
temporarily relieves minor aches and pains due to: headache, the common cold, backache, minor pain of arthritis, toothache, muscular aches, premenstrual and menstrual cramps temporarily reduces fever
do not take more than directed adults and children 12 years and over: take 2 tablets every 6 hours while symptoms last; do not take more than 6 tablets in 24 hours, unless directed by a doctor; do not take for more than 10 days unless directed by a doctor children under 12 years: ask a doctor
Acetaminophen 500 mg
Pain reliever/fever reducer
Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take
Allergy alert: Acetaminophen may cause severe skin reactions. Symptoms may include:
If a skin reaction occurs, stop use and seek medical help right away.
liver disease.
taking the blood thinning drug warfarin.
These could be signs of a serious condition.
ask a health professional before use.
In case of accidental overdose, get medical help or contact a Poison Control Center right away. Prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
castor oil, corn starch, hypromellose, polyethylene glycol, povidone, pregelatinized starch, sodium starch glycolate, starch, steric acid, titanium dioxide
1-877-973-2811 Monday-Friday 8:00 AM-5:00 PM
Compare to the active ingredient in Extra Strength Tylenol®*
MAXIMUM STRENGTH
ACETAMINOPHEN
Active Ingredient:
Acetaminophen
Pain Reliever / Fever Reducer
Xpect® First aid
WORKPLACE READY®
100 Tablets • 50 Packets (2 Tablets in each Packet) per Box
Compare to the active ingredient in Extra Strength Tylenol®*
MAXIMUM STRENGTH
ACETAMINOPHEN
Active Ingredient:
Acetaminophen
Pain Reliever / Fever Reducer
Xpect® First aid
WORKPLACE READY®
250 Tablets • 125 Packets )2 Tablets in each Packet) per Box
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42961-399-01 | Xpect Acetaminophen | 2 in 1 PACKET | TABLET | 2 | 11 | |
| 42961-399-04 | Xpect Acetaminophen | 100 in 1 BOX | TABLET | 100 | 11 | |
| 42961-399-05 | Xpect Acetaminophen | 250 in 1 BOX | TABLET | 250 | 11 | |
| 42961-399-06 | Xpect Acetaminophen | 25 in 1 BAG | TABLET | 25 | 11 | |
| 42961-399-07 | Xpect Acetaminophen | 50 in 1 BOX | TABLET | 50 | 11 | |
| 42961-399-08 | Xpect Acetaminophen | 125 in 1 BOX | TABLET | 125 | 11 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 42961-399 | 42961-399-01, 42961-399-05, 42961-399-04, 42961-399-06, 42961-399-07, 42961-399-08 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ACETAMINOPHEN | 362O9ITL9D | ACTIB |
| CASTOR OIL | D5340Y2I9G | IACT |
| STARCH, CORN | O8232NY3SJ | IACT |
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
| POLYETHYLENE GLYCOL, UNSPECIFIED | 3WJQ0SDW1A | IACT |
| POVIDONE, UNSPECIFIED | FZ989GH94E | IACT |
| SODIUM STARCH GLYCOLATE TYPE A | H8AV0SQX4D | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| TITANIUM DIOXIDE | 15FIX9V2JP | IACT |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 10 | 2025-09-22 | full-release | 2026-06-01 01:14:30 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Xpect Acetaminophen | ACETAMINOPHEN | Cintas Corporation | f4aed854-730e-493d-b523-122156e08dde | 2026-01-09 | Warnings | 42961-399-07 42961-399-04 42961-399-05 42961-399-06 42961-399-01 42961-399-08 42961-399 42961039905 42961039906 42961039908 42961039907 42961039901 42961039904 d231c65a-329e-444c-8898-d696efc9583e f4aed854-730e-493d-b523-122156e08dde |
Adverse event summaries are temporarily unavailable. Other product information remains available.